Winston Competitors

Stocks . Taiwan . 
Stock . Winston Medical Supply
6817 Stock  TWD 82.90  0.50  0.60%   
Winston Medical Supply competes with Tsh Biopharmoration, LIWANLI Innovation, InnoPharmax, Crystalvue Medical, and GeneFerm Biotechnology; as well as few others. The company operates under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. Analyzing Winston Medical competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Winston Medical to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Winston Medical Correlation with its peers.

Winston Medical vs BenQ Medical Correlation

Very good diversification

The correlation between Winston Medical Supply and 4116 is -0.21 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Winston Medical Supply and 4116 in the same portfolio, assuming nothing else is changed.

Moving against Winston Stock

  0.454114 Synmosa BiopharmaPairCorr
  0.386674 Compal Broadband NetworksPairCorr
  0.380053 YuantaP shares TaiwanPairCorr
  0.358086 Advanced WirelessPairCorr
  0.353257 Champion MicroelectronicPairCorr
Hype
Prediction
LowEstimatedHigh
81.0282.9084.78
Details
Intrinsic
Valuation
LowRealHigh
70.2172.0991.19
Details
Naive
Forecast
LowNextHigh
80.0781.9583.84
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
77.9882.8987.80
Details

Winston Medical Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Winston Medical and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Winston and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Winston Medical Supply does not affect the price movement of the other competitor.

High positive correlations

4116
+ 0.8
6527
4132
+ 0.79
8432
4111
+ 0.74
6527
4116
+ 0.67
4111
4132
+ 0.65
4172
3054
+ 0.61
8432
  

High negative correlations

6527
- 0.81
3054
4132
- 0.71
1780
1780
- 0.71
8432
4132
- 0.7
6527
4116
- 0.68
4132
6527
- 0.63
8432

Risk-Adjusted Indicators

There is a big difference between Winston Stock performing well and Winston Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Winston Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
8432  0.88  0.01 (0.06) 0.00  1.08 
(1.08)
 1.85 
(1.45)
 8.37 
3054  1.43  0.36  0.15 (2.49) 1.37 
(1.73)
 3.39 
(2.54)
 14.35 
4172  2.35  0.00 (0.03) 0.05  2.45 
(3.82)
 9.31 
(4.26)
 19.46 
6527  0.62 (0.13) 0.00 (1.40) 0.00 
 0.00 
 2.01 
(1.10)
 5.09 
1796  1.19 (0.17) 0.00  1.28  0.00 
 0.00 
 2.58 
(2.83)
 7.77 
6846  0.73 (0.02)(0.06) 0.02  0.91 
(0.98)
 1.91 
(1.71)
 5.90 
4111  0.47 (0.03) 0.00 (0.62) 0.00 
 0.00 
 0.83 
(1.03)
 2.51 
1780  1.50  0.21  0.10  0.53  1.33 
(1.96)
 3.66 
(2.95)
 14.51 
4132  4.22  0.70  0.12 (1.45) 4.49 
(5.01)
 12.15 
(6.05)
 45.53 
4116  0.70 (0.11) 0.00 (1.42) 0.00 
 0.00 
 1.16 
(1.81)
 5.70 

Winston Medical Competitive Analysis

The better you understand Winston Medical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Winston Medical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Winston Medical's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
6817 8432 3054 4172 6527 1796 6846 4111 1780 4132
 0.60 
 82.90 
Winston
 0.90 
 56.20 
Tsh
 0.83 
 29.95 
LIWANLI
 0.63 
 16.10 
InnoPharmax
 0.52 
 77.20 
Crystalvue
 0.33 
 45.00 
GeneFerm
 0.81 
 74.50 
Greenyn
 0.34 
 29.70 
Chi
 1.38 
 25.80 
Allied
 2.31 
 16.95 
Golden
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Very steady
Not too volatile
Very steady
Very steady
Very steady
Very steady
Very steady
Slightly risky
Market Performance
(90 Days Performance)
Weakest
Soft
Good
Weakest
Weakest
Weakest
Weak
Weakest
Fair
Fair
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Low
Small
High
Low
Low
Unknown
Low
Low
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Under Valued
Over Valued
Fairly Valued
Fairly Valued
Over Valued
Fairly Valued
Fairly Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Cautious Hold
Strong Sell
Strong Hold
Strong Sell
Sell
Strong Sell
Cautious Hold
Cautious Hold
Strong Hold
Strong Sell
Current Ratio
1.65
5.36
10.27
3.74
3.44
1.98
N/A
N/A
2.19
2.78
Net Asset
N/A
1.17 B
947.9 M
N/A
N/A
1.32 B
N/A
1.66 B
N/A
N/A
Profit Margin
24.57
0.15
-2.88
-152.85
11.53
0.15
N/A
0.12
19.15
N/A
EBITDA
177.79 M
71.41 M
65.26 M
(70.64 M)
89.04 M
123.07 M
N/A
185 M
190.03 M
(279.28 M)
Operating Margin
24.46
0.16
-1.15
-142.06
12.73
0.17
N/A
0.11
19.21
-414.69
Current Valuation
1.22 B
1.17 B
1.2 B
641.19 M
1.16 B
2.48 B
N/A
1.57 B
1.49 B
5.17 B
Price To Book
4.51
1.77
2.04
1.34
3.26
2.94
N/A
1.32
1.48
6.75
Five Year Return
N/A
3.54
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Retained Earnings
N/A
N/A
18 M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Asset
N/A
N/A
794 M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Beta
N/A
-0.0266
0.0508
0.11
0.07
0.89
N/A
0.25
0.24
0.72
Number Of Employees
N/A
80
19
38
94
12
N/A
11
11
135
Shares Outstanding
18.17 M
38.4 M
80.65 M
70.55 M
21.05 M
41.46 M
N/A
56.98 M
94.6 M
115.76 M
Cash Flow From Operations
169.12 M
68.71 M
(61.13 M)
(70.17 M)
101.33 M
112.23 M
N/A
139.33 M
172.94 M
(306.43 M)
Annual Yield
N/A
0.0319
N/A
N/A
N/A
0.0139
N/A
0.0368
N/A
N/A
Total Debt
136.16 M
7.01 M
2.13 M
N/A
N/A
31.25 M
N/A
N/A
484.99 M
227.3 M
Return On Equity
53.39
0.0635
-0.12
-14.75
15.83
0.12
N/A
0.12
12.11
-36.95
Z Score
5.4
N/A
N/A
N/A
N/A
61.8
N/A
N/A
1.8
13.2
Return On Asset
13.76
0.0387
-0.0274
-8.13
8.26
0.0534
N/A
0.0457
4.62
-17.85
Book Value Per Share
16.2
27.67
9.56
7.7
21.6
19.63
N/A
20.22
11.93
6.59
Current Liabilities
N/A
N/A
409 M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Asset
N/A
1.17 B
947.9 M
N/A
N/A
1.32 B
N/A
1.66 B
N/A
N/A
Debt To Equity
0.39
0.6
0.002
N/A
N/A
0.72
N/A
N/A
43.0
30.1
Last Dividend Paid
3.0
1.5
N/A
N/A
1.73
N/A
N/A
1.0
1.0
N/A
Shares Owned By Institutions
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Market Capitalization
1.33 B
1.78 B
1.52 B
715.45 M
1.48 B
3.22 B
N/A
1.56 B
1.66 B
5.15 B
Price To Earning
13.01
56.63
156.1
N/A
21.83
53.28
N/A
N/A
12.39
N/A
Price To Sales
2.26
4.22
45.98
12.66
2.45
4.16
N/A
1.34
2.38
65.71
Net Income
144.27 M
47.11 M
45.56 M
(86.35 M)
69.89 M
57.41 M
N/A
80.75 M
134.05 M
(336.49 M)
Earnings Per Share
5.62
1.78
0.18
-1.23
3.23
2.18
N/A
2.33
1.42
-2.97
Shares Owned By Insiders
N/A
64.94
81.86
N/A
N/A
57.17
N/A
25.88
N/A
N/A
Revenue
587.22 M
413.48 M
47.81 M
56.49 M
606.31 M
522.33 M
N/A
1.04 B
699.9 M
78.35 M
Working Capital
N/A
N/A
385 M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash And Equivalents
238.7 M
708.28 M
661.45 M
99.55 M
347.53 M
619.1 M
N/A
N/A
676.58 M
152.56 M
Cash Per Share
13.14
18.36
7.93
1.41
16.25
15.32
N/A
N/A
7.17
1.33
Gross Profit
203.82 M
247.36 M
7.54 M
27.82 M
187.94 M
192.65 M
N/A
346.84 M
301.27 M
51.31 M
Day Typical Price
82.47
56.27
29.72
15.93
76.97
45.0
74.33
29.75
25.7
16.78
Accumulation Distribution
0.044
0.0106
0.0267
0.0372
0.0091
0.0044
0.0067
0.0084
0.0155
0.086
Market Facilitation Index
3.7
0.6
0.8
0.6
0.7
0.2
0.5
0.25
0.4
1.5
Daily Balance Of Power
(0.14)
0.8333
(0.31)
0.1667
0.5714
0.75
1.2
(0.40)
0.875
(0.27)
Period Momentum Indicator
(0.50)
0.5
(0.25)
0.1
0.4
0.15
0.6
(0.10)
0.35
(0.40)
Rate Of Daily Change
0.99
1.01
0.99
1.01
1.01
1.0
1.01
1.0
1.01
0.98
Day Median Price
82.25
56.3
29.6
15.85
76.85
45.0
74.25
29.78
25.65
16.7
Price Action Indicator
0.4
0.15
0.22
0.3
0.55
0.075
0.55
(0.12)
0.33
0.05
Relative Strength Index
N/A
51.81
58.35
N/A
46.91
42.04
52.12
49.87
N/A
45.01
Coefficient Of Variation
(446.08)
12080.41
580.7
232069.4
(863.18)
(944.76)
5941.31
(3,119)
999.91
953.05
Mean Deviation
1.34
0.8784
1.43
2.35
0.6219
1.19
0.7308
0.4741
1.5
4.22
Jensen Alpha
(0.46)
0.0123
0.3564
0.0034
(0.13)
(0.17)
(0.02)
(0.03)
0.2055
0.7011
Total Risk Alpha
(0.61)
(0.12)
0.1534
(0.33)
(0.22)
(0.32)
(0.09)
(0.08)
0.0064
0.0649
Sortino Ratio
N/A
(0.06)
0.1508
(0.03)
N/A
N/A
(0.06)
N/A
0.1013
0.1199
Downside Variance
N/A
1.41
3.41
6.79
N/A
N/A
1.06
N/A
2.75
25.15
Standard Deviation
1.9
1.24
2.07
3.45
0.9844
1.56
1.05
0.5804
2.46
6.48
Kurtosis
1.28
3.53
6.12
3.18
4.31
0.2423
1.69
(0.40)
13.42
8.23
Potential Upside
3.49
1.85
3.39
9.31
2.01
2.58
1.91
0.8251
3.66
12.15
Treynor Ratio
(1.25)
(0)
(2.49)
0.0487
(1.40)
1.28
0.0217
(0.62)
0.5259
(1.45)
Maximum Drawdown
8.49
8.37
14.35
19.46
5.09
7.77
5.9
2.51
14.51
45.53
Variance
3.63
1.55
4.29
11.87
0.9691
2.45
1.11
0.3369
6.06
41.94
Market Risk Adjusted Performance
(1.24)
0.0083
(2.48)
0.0587
(1.39)
1.29
0.0317
(0.61)
0.5359
(1.44)
Risk Adjusted Performance
(0.16)
0.0102
0.1325
0.0082
(0.08)
(0.07)
0.0154
(0.03)
0.0802
0.0857
Skewness
0.3564
0.4466
1.37
1.09
1.14
0.2061
0.0049
(0.36)
2.89
1.89
Semi Deviation
N/A
1.08
1.37
2.45
N/A
N/A
0.9091
N/A
1.33
4.49
Information Ratio
(0.27)
(0.05)
0.1344
(0.02)
(0.20)
(0.16)
(0.06)
(0.17)
0.0682
0.0928
Value At Risk
(3.49)
(1.45)
(2.54)
(4.26)
(1.10)
(2.83)
(1.71)
(1.03)
(2.95)
(6.05)
Expected Short fall
N/A
(1.08)
(1.73)
(3.82)
N/A
N/A
(0.98)
N/A
(1.96)
(5.01)
Downside Deviation
N/A
1.19
1.85
2.61
N/A
N/A
1.03
N/A
1.66
5.02
Semi Variance
N/A
1.18
1.88
6.01
N/A
N/A
0.8264
N/A
1.78
20.15

Winston Medical Competition Performance Charts

Five steps to successful analysis of Winston Medical Competition

Winston Medical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Winston Medical Supply in relation to its competition. Winston Medical's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Winston Medical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Winston Medical's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Winston Medical Supply, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Winston Medical position

In addition to having Winston Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Money Market Funds Thematic Idea Now

Money Market Funds
Money Market Funds Theme
Funds or Etfs investing in various types of short-term (less than one year) fixed income instruments of high-quality and liquidity. The Money Market Funds theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Money Market Funds Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Winston Stock Analysis

When running Winston Medical's price analysis, check to measure Winston Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Winston Medical is operating at the current time. Most of Winston Medical's value examination focuses on studying past and present price action to predict the probability of Winston Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Winston Medical's price. Additionally, you may evaluate how the addition of Winston Medical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY